RemedyRepack Inc. 2022-01-19 Health serious FDA
Health · FDA · Recall #FDA-D-0366-2022
Metformin 750 mg Extended Release NDC # 70518-2920-00 Recall
Issued January 19, 2022 · RemedyRepack Inc.
In January 2022, RemedyRepack Inc. recalled the Metformin 750 mg Extended Release NDC # 70518-2920-00, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.
What you should do
- 1 Stop using Metformin 750 mg Extended Release NDC # 70518-2920-00 right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact RemedyRepack Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- RemedyRepack Inc.
- Category
- Health
- Recall date
- January 19, 2022
- Units affected
- Not reported
- Sold at
- Product was distributed to one direct account in PA.
- Recall number
- FDA-D-0366-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- RemedyRepack Inc. has 12 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.